Related Experiment Video
Updated: Nov 21, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Management of Cardiac Sarcoidosis in 2020
Nisha Gilotra1, David Okada1, Apurva Sharma1
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, US.
Insights
Cardiac sarcoidosis (CS) is an inflammatory condition affecting the heart, presenting with arrhythmias and heart failure. Advanced imaging aids diagnosis, while updated management focuses on immunosuppression and targeted therapies.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Sarcoidosis is a multisystem inflammatory disease.
- Cardiac involvement occurs in up to 25% of systemic sarcoidosis patients.
- Cardiac sarcoidosis (CS) presents with diverse clinical manifestations.
Purpose of the Study:
- To provide an update on the diagnosis and management of cardiac sarcoidosis.
- To review clinical manifestations, diagnostic imaging, and therapeutic strategies for CS.
- To identify knowledge gaps and future research directions in CS.
Main Methods:
- Review of current literature on cardiac sarcoidosis diagnosis and management.
- Emphasis on the role of advanced cardiac imaging in identifying CS.
- Discussion of updated treatment protocols including immunosuppression and supportive therapies.
Main Results:
- Diagnosis of CS is improving with advanced cardiac imaging.
- Clinical manifestations include heart block, arrhythmias, and heart failure.
- Corticosteroids are standard, with evolving roles for steroid-sparing agents.
Conclusions:
- Early diagnosis and management of CS are crucial.
- Multidisciplinary approach is essential for optimal patient outcomes.
- Further research is needed to refine treatment strategies and address knowledge gaps.
Abstract:
Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The clinical manifestations of cardiac sarcoidosis (CS) include heart block, atrial arrhythmias, ventricular arrhythmias and heart failure. The diagnosis of CS can be challenging given the patchy infiltration of the myocardium but, with the increased availability of advanced cardiac imaging, more cases of CS are being identified. Immunosuppression with corticosteroids remains the standard therapy for the acute inflammatory phase of CS, but there is an evolving role of steroid-sparing agents. In this article, the authors provide an update on the diagnosis of CS, including the role of imaging; review the clinical manifestations of CS, namely heart block, atrial and ventricular arrhythmias and heart failure; discuss updated management strategies, including immunosuppression, electrophysiological and heart failure therapies; and identify the current gaps in knowledge and future directions for cardiac sarcoidosis.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

